Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Accuray Incorporated To Acquire Morphormics, Inc.
Accuray Incorporated announced that they have signed a definitive agreement to acquire Morphormics, Inc., a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images. The agreement provides that Accuray will pay approximately $5.7 million.
Latest Developments for Accuray Inc
- Accuray Inc Reaffirms FY 2013 Revenue Guidance; Issues Q3 2013 Revenue Guidance In Line With Analysts' Estimates-Conference Call
- Accuray Inc Issues Q2 2013 Guidance; Revenue Guidance In Line With Analysts' Estimates; Lowers FY 2013 Guidance-Conference Call
- 90 Presentations At Radiation Oncology Meeting Demonstrate Breadth And Depth Of Clinical Evidence For Accuray Inc
- Accuray Inc Announces Resignation Of President And Chief Executive Officer
Latest Key Developments in Advanced
- Waters Corp Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Guidance-Conference Call
- Hologic Inc Updates FY 2013 Guidance To A Range In Line With Analysts' Estimates-Conference Call
- Arrhythmia Research Technology Inc Issues Q1 2013 Guidance; Announces Delay In Finalizing First Quarter Of 2013 Results
- Biosensors International Group Ltd Announces Incorporation Of New Subsidiaries
- Share this
- Link this
- Digg this
Follow Reuters